Replies to post #810191 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

Exactly right . But again, ILT and his aliases don't like facts if they don't go their narrative 

[ilovetech]

 
 THE 2026 RULEBOOK VS. THE 2025 NOSTALGIA 
 The critic is citing UKLR 14 "home markets." 
 He’s reading the wrong chapter. Tomorrow is 
 about the POATR Reset. Here is the Hardware: 
 1. THE 75% BYPASS 
 As of Monday, the "Regulated Home Market" 
 argument is secondary to the 75% Prospectus 
 Exemption. If NWBO uses a NewCo (RevImmune), 
 the "OTC Disqualification" is a moot point. 
 The Gate is now a "Self-Service" portal.   
 2. THE "2-DAY" CONFIDENTIALITY 
 New SEC and FCA rules (Jan 2026) allow 
 confidentiality until 48 hours before 
 effectiveness. The "Public Process" he 
 demands is a relic of 2024. The RNS IS the 
 notification. 
 3. THE PROXY MISCONCEPTION 
 Authorized share increases are NEVER specific 
 to a listing in a Proxy—that would be 
 "Gun-Jumping." The Jan 15th settlement was 
 the Gavel; the Proxy was the lumber. 
  
 SUMMARY: 
 The long is arguing against a wall that was 
 demolished by Notice N01/26 on Friday. He 
 wants a "Process"; the LSE just gave us a 
 "Switch."